Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19.
Al-Chalabi A, Chiò A, Merrill C, Oster G, Bornheimer R, Agnese W, Apple S. Al-Chalabi A, et al. Among authors: agnese w. J Neurol Neurosurg Psychiatry. 2021 Feb;92(2):165-171. doi: 10.1136/jnnp-2020-323271. Epub 2020 Oct 27. J Neurol Neurosurg Psychiatry. 2021. PMID: 33109706 Free PMC article. Clinical Trial.
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study Design.
Berry J, Brooks B, Genge A, Heiman-Patterson T, Appel S, Benatar M, Bowser R, Cudkowicz M, Gooch C, Shefner J, Westra J, Agnese W, Merrill C, Nelson S, Apple S. Berry J, et al. Among authors: agnese w. Neurol Clin Pract. 2021 Aug;11(4):e472-e479. doi: 10.1212/CPJ.0000000000000968. Neurol Clin Pract. 2021. PMID: 34476128 Free PMC article.
Post-hoc analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosis.
Palumbo JM, Hubble J, Apple S, Takei K, Tsuda K, Liu S, Zhang J, Agnese W. Palumbo JM, et al. Among authors: agnese w. Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):421-431. doi: 10.1080/21678421.2019.1599955. Epub 2019 Apr 13. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 30982356
Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis tool.
Brooks BR, Pioro EP, Beaulieu D, Taylor AA, Schactman M, Keymer M, Agnese W, Perdrizet J, Apple S, Ennist DL. Brooks BR, et al. Among authors: agnese w. Amyotroph Lateral Scler Frontotemporal Degener. 2022 Feb;23(1-2):49-57. doi: 10.1080/21678421.2021.1927102. Epub 2021 Jul 10. Amyotroph Lateral Scler Frontotemporal Degener. 2022. PMID: 34251911
12 results